Jennifer McElhattan

Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement

Charles W. Francis, Scott D. Berkowitz, Philip C. Comp et al. · New England Journal of Medicine · 2003 · 318 citations

Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Donald P. Tashkin, Jennifer McElhattan et al. · Drugs · 2009 · 182 citations · Full text

Asthma, Advanced Lung Disease, Medicine +6

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study

Clifford W. Colwell, Scott D. Berkowitz, Bruce L. Davidson et al. · Journal of Thrombosis and Haemostasis · 2003 · 142 citations

Thrombosis, Venous Disease, Venous Thrombosis +11

Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials

Jonathan A. Bernstein, J. Christian Virchow, Kevin R. Murphy et al. · The Lancet Respiratory Medicine · 2020 · 79 citations

Asthma, Fixed-dose Subcutaneous Reslizumab, Allergy +5

A double-blind, randomised trial of tesaglitazar versus pioglitazone in patients with type 2 diabetes mellitus

Harold Bays, Jennifer McElhattan, Brian Bryzinski · Diabetes and Vascular Disease Research · 2007 · 50 citations · Full text